Edesa Biotech, Inc. (EDSA) Q3 2024 Annual Earnings
EDSA·Reported December 13, 2024·Before market open
Diluted EPS came in at $-0.29, beat the $-0.54 consensus by $0.25.
Diluted EPS
$-0.29beat by $0.25
Consensus: $-0.54
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Edesa Biotech, Inc.'s Q3 2024 earnings report.
Edesa Biotech, Inc. (EDSA) reported Q3 2024 earnings on December 13, 2024 before market open.
Edesa Biotech, Inc. reported diluted EPS of $-0.29 for Q3 2024.
EPS beat the consensus estimate of $-0.54 by $0.25.
You can read the 10-K periodic report (0001171843-24-006946) directly on SEC EDGAR. The filing index links above go to sec.gov.